-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Cytokinetics Inc quarterly/annual Operating Income (Loss) history and growth rate from 2010 to 2023.
- Cytokinetics Inc Operating Income (Loss) for the quarter ending June 30, 2024 was -$130M, a 6.66% decline year-over-year.
- Cytokinetics Inc Operating Income (Loss) for the twelve months ending June 30, 2024 was -$506M, a 5% decline year-over-year.
- Cytokinetics Inc annual Operating Income (Loss) for 2023 was -$496M, a 53.1% decline from 2022.
- Cytokinetics Inc annual Operating Income (Loss) for 2022 was -$324M, a 74% decline from 2021.
- Cytokinetics Inc annual Operating Income (Loss) for 2021 was -$186M, a 98.3% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)